Jiangsu Hengrui Pharmaceuticals Co Ltd
600276
Company Profile
Business description
Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.
Contact
No. 38, Huanghe Road, Economic
Economic and Technological Development Zone
Jiangsu Province
Lianyugang 222047
CHNT: +86 51885469805
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
19,611
Jiangsu Hengrui Pharmaceuticals Co Ltd News & Analysis
stocks
Stocks to watch as China bounces back
China’s faster than expected recovery from COVID-19 has analysts scrambling to revise their forecasts.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,217.00 | 25.10 | 0.31% |
| CAC 40 | 7,425.26 | 72.96 | 0.99% |
| DAX 40 | 18,443.56 | 141.66 | 0.77% |
| Dow JONES (US) | 40,829.59 | 484.18 | 1.20% |
| FTSE 100 | 8,270.84 | 89.37 | 1.09% |
| HKSE | 17,277.49 | 80.53 | 0.47% |
| NASDAQ | 16,884.60 | 193.77 | 1.16% |
| Nikkei 225 | 36,159.16 | 56.59 | -0.16% |
| NZX 50 Index | 12,632.82 | 11.20 | 0.09% |
| S&P 500 | 5,471.05 | 62.63 | 1.16% |
| S&P/ASX 200 | 8,011.90 | 23.80 | 0.30% |
| SSE Composite Index | 2,744.20 | 7.72 | 0.28% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Bowen Coking Coal Ltd BCB | 0.01 | 0.00 | -22.22% |
| Red 5 Ltd RED | 0.29 | 0.01 | -1.72% |
| Telstra Group Ltd TLS | 3.95 | 0.03 | 0.77% |
| Pilbara Minerals Ltd PLS | 2.36 | 0.05 | -2.07% |
| GPT Group GPT | 5.09 | 0.01 | -0.20% |
| Steadfast Group Ltd SDF | 5.32 | 0.64 | -10.74% |
| Appen Ltd APX | 1.34 | 0.10 | 7.63% |
| South32 Ltd S32 | 2.99 | 0.02 | 0.67% |
| Core Lithium Ltd CXO | 0.09 | 0.00 | 4.76% |
| Scentre Group SCG | 3.54 | 0.01 | -0.28% |